Economic evaluation of antimicrobial stewardship in primary care: a systematic review and quality assessment

Predicting therapeutic response to unfractionated heparin therapy: a methodological pilot study using machine learning

Correction to: Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm

Scoping review of studies evaluating frailty and its association with medication harm

A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial

Evaluation of two European risk models for predicting medication harm in an Australian patient cohort

The right time and place: the need for seven‐day pharmacist service models

Systematic review of machine learning models for personalised dosing of heparin

Determining causality, severity and preventability of inpatient medication harm, including related hospital-acquired complications, using clinical coding data

Medicinal mishap: death from diltiazem-ibrutinib interaction

The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis

Development and validation of the Adverse Inpatient Medication Event Model (AIME)

Vitamin D and the link with Parkinson’s disease: causal or correlational?

Identifying medication harm in hospitalised patients: a bimodal, targeted approach

How hospital pharmacists prioritise patients at high-risk for medication harm

Defining and classifying terminology for medication harm: a call for consensus

Reply to Iuga and Genaidy "Comment on Falconer et al. (2018) - the need for specific adverse drug reaction outcomes"

Systematic review of predictive risk models for adverse drug events in hospitalised patients

Validation of the assessment of risk tool: patient prioritisation technology for clinical pharmacist interventions

Development of an electronic patient prioritization tool for clinical pharmacist interventions